US Patent Issued to Northwestern University on Oct. 7 for "3-methylideneoxan-4-one compounds and substituted derivates thereof as inhibitors of telomerase" (Illinois Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,435,055, issued on Oct. 7, was assigned to Northwestern University (Evanston, Ill.).

"3-methylideneoxan-4-one compounds and substituted derivates thereof as inhibitors of telomerase" was invented by Karl A. Scheidt (Evanston, Ill.) and Rick C. Betori (Gurnee, Ill.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are 3-methylideneoxan-4-one compounds, derivatives thereof, and methods of their synthesis and methods of their use in treating a disease or disorder in a subject in need thereof, such as diseases and disorders that are associated with telomerase activity such as cancer. The disclosed compounds may be formulated in a pharmaceutical compos...